FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Canopy Health Innovations

  • Home
  •  | 
  • Tag Archives: "Canopy Health Innovations"

Canopy Growth announces clinical trial approval for the use of cannabis to treat anxiety in certain animals

Canopy Growth announces clinical trial approval for the use of cannabis to treat anxiety in certain animals
TORONTO and SMITHS FALLS, ON, Aug. 8, 2018 /CNW/ - Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or the "Company") and its wholly owned subsidiary, Canopy Health Innovations Inc. ("Canopy Health" or "CHI") is pleased to announce that approval has been received from the Veterinary Drug Directorate of Health Canada to research the effectiveness of cannabidiol ("CBD") to treat anxiety in certain animals. The research will be conducted by Canopy Animal Health ("CAH"), a division of Canopy Health which focuses on developing cannabis-based healthcare products for companion animals.
Read more

Canopy Growth Strengthens Commitment to Cannabis-Based Medicines Through Completion of Canopy Health Innovations Acquisition

Canopy Growth Strengthens Commitment to Cannabis-Based Medicines Through Completion of Canopy Health Innovations Acquisition
TORONTO and SMITHS FALLS, ON, Aug. 7, 2018 /CNW/ - Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or the "Company") is pleased to announce that it has completed the previously announced acquisition of Canopy Health Innovations Inc. ("CHI"), including the subsidiary operations of Canopy Animal Health Inc. ("CAH"). The Company believes its strategy of integrating and aligning CHI's clinical platform with the international work of Spectrum Cannabis, will accelerate its comprehensive research programs, build evidence around Canopy products and formulations and ultimately improve patient access to medical cannabis globally.
Read more